The combined effect of administration of intravenous and topical tranexamic acid on blood loss and transfusion rate in total knee arthroplasty: Combined tranexamic acid for TKA

OBJECTIVES: Tranexamic acid (TXA) is an antifibrinolytic agent used as a blood-sparing technique in total knee arthroplasty (TKA), and is routinely administered by intravenous (IV) or intra-articular (IA) injection. Recently, a novel method of TXA administration, the combined IV and IA application o...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Bone Joint Res
Main Authors: Yuan, Z. F., Yin, H., Ma, W. P., Xing, D. L.
Formato: Artigo
Idioma:Inglês
Publicado: 2016
Assuntos:
Knee
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5013895/
https://ncbi.nlm.nih.gov/pubmed/27587787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1302/2046-3758.58.BJR-2016-0001.R2
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares